Role(s) in Healthcare Innovation:
Other Physician Scientist / Researcher Educator Clinical InformaticsMy Communities
Global Healthcare Innovation AMIAWilliam Hersh, MD
Professor and Chair, Department of Medical Informatics & Clinical Epidemiology
Portland, Oregon United States
Higher Education, Portland, Oregon Area
About Me
William Hersh, MD, FACMI is Professor and Chair of the Department of Medical Informatics & Clinical Epidemiology at Oregon Health & Science University. He is a leader and innovator in biomedical informatics both in education and research. In education, he is Director of OHSU’s Biomedical Informatics Graduate Program and is known for innovations in distance learning. His research contributions have been in information retrieval and informatics workforce development. More information can be found on his Web site. He also maintains the Informatics Professor Blog.
Interested in solutions for:
For my communityI am looking for healthcare innovations:
You have not backed any projects.
Lets change that!
Discover Projects
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No likes on any project yet..
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.